Cargando…

Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682945/
https://www.ncbi.nlm.nih.gov/pubmed/38033470
http://dx.doi.org/10.3389/fchem.2023.1332615
_version_ 1785151085828112384
collection PubMed
description
format Online
Article
Text
id pubmed-10682945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106829452023-11-30 Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents Front Chem Chemistry Frontiers Media S.A. 2023-11-14 /pmc/articles/PMC10682945/ /pubmed/38033470 http://dx.doi.org/10.3389/fchem.2023.1332615 Text en Copyright © 2023 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
title Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
title_full Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
title_fullStr Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
title_full_unstemmed Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
title_short Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
title_sort retraction: design, synthesis, and biological evaluation of (e)-n’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682945/
https://www.ncbi.nlm.nih.gov/pubmed/38033470
http://dx.doi.org/10.3389/fchem.2023.1332615
work_keys_str_mv AT retractiondesignsynthesisandbiologicalevaluationofen1chloro34dihydronaphthalen2ylmethylenebenzohydrazidederivativesasantiprostatecanceragents